ClinicalTrials.gov
public full text
Public Domain
Evaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine Cytology
* This study includes two semi-consecutive parts: * Part I Open label, controlled, Calibration part aimed to calibrate the CellDetect® device for identifying bladder cancer cells in urine samples. * Part II Prospective, controlled, blinded part to determine the performance of the CellDetect® device in monitoring bladder cancer recurrence in patients with a history of TCC, using urine cytology samples * The following subjects will be enrolled: Subjects previously diagnosed with bladder cancer undergoing routine cystoscopic surveillance, TURT or Cystectomy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL#862365
- Characterisation of Urine-Derived Cells for the Molecular Diagnosis of Rare Disorders.#9157
- A Multicenter Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening#1126444
- To Detect the Sensitivity of the UroMark Assay#875777
- Evaluation of VISIOCYT Bladder Cytology in Real Life#1096530
Record · ID 1137637
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive